Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORRECT: Different Regimens for Diabetic Retinopathy in Type 2 Diabetes
NCT02587741Phase 1Unknown
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2015
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of liquid metformin (Aspargo Labs), insulin glargine and biphasic insulin aspart in diabetic retinopathy (DR), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)insulin glarginebiphasic insulin aspart
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT02587741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587741.